Analysis of mitochondrial DNA allelic changes in Parkinson’s disease: a preliminary study

3Citations
Citations of this article
11Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Background: Mitochondrial DNA (mtDNA) mutations are considered as a possible primary cause of age-associated neurodegenerative disorders like Parkinson’s disease (PD). Aims: To analyze, along the whole mtDNA sequence of PD patients, the presence of non-reference alleles compared to reference alleles, as defined in the revised Cambridge Reference Sequence (rCRS). Methods: mtDNA was extracted from whole blood of PD and control groups, and was sequenced using a chip-based resequencing system. Results: 58 nucleotide positions (np) exhibited a different allelic distribution in the two groups; in 81% of them the non-reference alleles were over-represented in PD patients, similar to findings reported in patients with Alzheimer’s disease, albeit in reduced proportion. Closer analysis of the 58 np in PD group showed that they were characterized by low-level heteroplasmy, and that the nucleotide substitutions determined an amino acid change in 84% of cases. Conclusions: These results suggest that mtDNA allelic changes are increased in PD and that age-related neurodegenerative diseases could share a common mechanism involving mtDNA.

Cite

CITATION STYLE

APA

Casoli, T., Lisa, R., Fabbietti, P., & Conti, F. (2020). Analysis of mitochondrial DNA allelic changes in Parkinson’s disease: a preliminary study. Aging Clinical and Experimental Research, 32(2), 345–349. https://doi.org/10.1007/s40520-019-01197-4

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free